Gliclazide Api

Product Description

Gliclazide is used for control of hyperglycemia in gliclazide-responsive diabetes mellitus of stable, mild, non-ketosis prone, type 2 diabetes. It is used when diabetes cannot be controlled by proper dietary management and exercise or when insulin therapy is not appropriate.

Superior Purity and Stability

Gliclazide API offers 99% purity, making it ideal for pharmaceutical applications. Its stable, powdered form ensures consistent dosing and easy handling throughout the formulation process. The product's shelf life extends to 5 years, providing reliable storage and longevity, thereby supporting large-scale production and supply continuity for diabetes medications.


Comprehensive Applications

As a pharmaceutical intermediate, Gliclazide API is utilized primarily in the development of anti-diabetic medications for type 2 diabetes. Its proven efficacy helps healthcare professionals maintain glycemic control in patients who are not prone to ketosis, offering a targeted approach for stable and mild diabetic cases. Manufacturers benefit from a high-standard ingredient to ensure product effectiveness.